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Abstract Humanity has faced several foes over the centuries, 
a formidable one amongst them is the current pan-
demic of COVID-19. The symptoms of COVID-19 
are more or less related to the nose and throat. There-
fore, patients more often present to Ear Nose Throat 
(ENT) clinics with symptoms including cough, sore 
throat, fever and shortness of breath. In the manage-
ment of head and neck pathologies, as the airway is a 
direct source of infection, the impact of COVID-19 
holds special significance. This review has attempted 
to explain the various aspects of the disease itself, its 
diagnosis, the use of personal protective equipment 
(PPE) to provide an overview of the evolving recom-
mendations in head and neck patients, the future out-
look and the limitations faced in developing countries 
specifically for ENT patients.
Keywords: COVID-19, otorhinolaryngology, pan-
demics, elective surgical procedures
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Introduction
Humanity has faced several foes over the centuries, 
a formidable one amongst them is the current pan-
demic of Corona virus disease of 2019 (COVID-19). 
It is believed that it originated in Wuhan, the capital 
city of Hubei province in the People’s Republic of 
China, COVID-19 was labelled as a public health 
emergency of international significance by World 
Health Organization (WHO) in January 2020 (1). 
The issue has raised hurdles in healthcare provision 
in all medical sectors and has been dealt with in dif-
ferent ways. The pandemic is a stark reminder of the 
emerging trends in infectious diseases and the need 
for the constant evolution of healthcare.
In the management of head and neck pathologies, 
as the airway is a direct source of infection, the 
impact of COVID-19 holds special significance 
(2). This review article has attempted to explain 
the various aspects of the disease itself, providing 
an overview of the evolving recommendations for 
head and neck patients, the future outlook and the 
limitations faced in developing countries, specifi-
cally for otorhinolaryngology patients.
What Is COVID-19?
A brief history of Coronavirus
In the past two decades, there have been two cat-
astrophic events where the Coronavirus crossing 
over from animal to humans has resulted in se-
vere disease. In 2002-2003, a new coronavirus of 
β-genera originating from bats and crossing over 
to humans via cats was designated as severe acute 
respiratory syndrome coronavirus (SARS-CoV). 
This virus affected 8,422 people, mostly in Guang-
dong province of China and some parts of Hong 
Kong and caused more than 900 deaths with a 
mortality rate of 11% (3). A decade later, anoth-
er virus of bat origin emerged in Saudi Arabia in 
2012 and was named as the Middle East respira-
tory syndrome coronavirus (MERS-CoV). Drom-
edary camels acted as the intermediate host and 
up to 2,500 people were affected, out of whom 858 
lost their lives with a fatality rate of 34% (4).
Viral etiology
According to the recent literature, SARS-CoV-2 
resembles SARS-CoV and MERS-CoV. Being 
zoonotic, its probable origin is from horseshoe bats and pango-
lins acting as the most likely intermediate hosts (5, 6).
Epidemiological considerations
Mode of transmission: on the basis of epidemiological research and 
the data available, it seems that the COVID-19 outbreak initially 
began from an animal to the human transmission which then led 
to human to human spread (7). It is now suggested that this inter-
personal spread is due to contact transmission and via respiratory 
droplets (8). Studies have found SARS-CoV-2 in the stool of few 
patients with COVID-19 in China and the United States, and it 
is considered that there may be a risk of fecal-oral transmission as 
well (7). Although the spread of this virus through aerosols and 
from mothers to newborn need yet to be confirmed (9, 10).
Source of transmission: The main sources of transmission of 
the disease are those individuals who have tested positive for 
COVID-19. Other than that, recent studies and observations 
suggested that asymptomatic patients and those in their incuba-
tion period also act as carriers of SARS-CoV-2 and transmit the 
disease. It is questionable whether or not patients in the recovery 
phase are source of transmission (5, 11).
Incubation period: The estimated incubation period of COVID-19 
is 5 to 6 days on the average. This can, however, go up to 14 days, 
which, therefore, is adopted as the observation and quarantine 
period for exposed persons (7). Few studies in the literature also 
reported incubation periods up to 24 days (12).
Mortality rate: Current data suggests that mortality rate of 
COVID-19 is 0.39% to 4.05% and comparatively lower than 
those of SARS (mortality rate up to 10%) and MERS (mortal-
ity rate up to 34%). It is also higher than the mortality rate of 
seasonal influenza, which accounts for up to 0.01% to 0.17% (7).
People at high risk: People of all ages are found to be susceptible 
to this disease. Although people who have close contact with 
patients infected with COVID-19, including healthcare profes-
sionals and other patients admitted in the hospital are at higher 
risk (13). People with immunosuppression, multiple comorbid-
ities and old age are considered to be at risk to become victims 
of this infection.
Clinical manifestations and complications
Infection is slightly more male predominant with a rate ranging 
around 58% (14). The symptoms of COVID-19 are more or less 
related to the nose and throat. Therefore, patients more often 
present to Ear Nose Throat (ENT) clinics with symptoms in-
cluding cough, sore throat, fever and shortness of breath. Other 
atypical symptoms can include fatigue, headache, diarrhea, vom-
iting and confusion (13). Since some patients from China, Italy 
and Iran have reported anosmia and dysgeusia, these should also 
be considered when screening patients for COVID-19 (15).
One-fourth to one-third of hospitalized patients may require 
intensive care support and can develop complications such as 
acute respiratory distress syndrome, arrhythmia, shock, acute 
kidney injury and acute liver disease, ultimately leading to the 
vicious cycle of multi-organ failure and death (7).
Diagnosis and treatment
Laboratory workup may show raised C-reactive protein (CRP), 
lactate dehydrogenase (LDH) and erythrocyte sedimentation 
rate (ESR) levels along with lymphocytopenia (16). Since chest 
X-ray and chest computed tomography (CT) show nonspecific 
findings, the American College of Radiology (ACR) and the 
Society of Thoracic Radiologists recommend that these tech-
niques are not used for screening or for diagnostic purposes. 
ACR recommended computed tomography (CT) should not be 
used as first-line test to diagnose this condition but should be 
reserved for hospitalized and symptomatic patients and appro-
priate infection control measures should be taken before scan-
ning subsequent patients. Furthermore, ACR suggested that a 
normal CT does not rule out COVID-19 infection and an ab-
normal CT is not specific for COVID-19 diagnosis (2).
Currently, the diagnosis of COVID-19 is made with polymerase 
chain reaction (PCR) testing for nucleic acid sequence homology 
in nasopharyngeal or throat swabs. The preferred site is the naso-
pharynx because of the higher viral load (17). The range of sensi-
tivity of the PCR test reported in literature is from 30% to 60%. 
This low sensitivity may be due to multiple external factors in-
cluding inappropriate sampling technique or collection, transpor-
tation and quality or performance of the kits (18). Single negative 
PCR test result from a suspected COVID-19 patient does not ex-
clude the infection and may become positive on repeating the test, 
and therefore we should be alert of the patients with COVID-19 
related symptoms and suspected history (2). Serological testing 
for COVID-19 is currently under development (19).
In a video, Marty et al. (20) demonstrated the proper technique 
of obtaining specimens from the surface of the respiratory mu-
cosa with nasopharyngeal swabs for the diagnosis of COVID-19 
in adults and children.
Until now, there is no specific treatment available against this 
infection, and therefore the current management of COVID-19 
is to control the source of infection with the help of infection 
control measures to decrease the risk of its transmission and 
provision of early diagnosis, isolation and supportive care (7).
Main Points
• The symptoms of COVID-19 are more or less related to the 
nose and throat including cough, sore throat, fever, anosmia, 
dysgeusia and shortness of breath. 
• Hospitalized patients may require intensive care support and 
can develop complications such as acute respiratory distress 
syndrome, arrhythmia, shock, acute kidney injury, ultimately 
leading to multi-organ failure and death.
• PPEs reduce risk of nosocomial infections, AAOHNS advo-
cated adherence to respiratory droplet precautions by using eye 
protection, gown, gloves and masks (N95 for procedures).
• Guidelines are being updated on almost daily basis, proper use 
of PPE and a more stringent selection of patients for examina-
tion and surgical procedures the risk can be minimized.
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Infection Control
Risk of nosocomial infection
The risk of nosocomial infection stems from multiple factors: 
at the start of the pandemic, healthcare personnel did not have 
adequate knowledge about the nature of the spread of the virus 
and that led to incomplete protective measures, the increasing 
workload led to fatigue, which in turn increased the probability 
of acquiring the infection, and later in the course of the pan-
demic shortage of personal protective equipment (PPE) itself 
became a grave concern (21). 
Infection control guidelines and protocols
Various institutions introduced protocols to control infection 
spread amongst healthcare workers (HCW). One Chinese hos-
pital divided the strategy into branches like material allocation, 
infection control training, a triage strategy, reducing hospi-
tal traffic, and a cleaner environment. They kept waiting-areas 
apart, reduced appointments, relieved HCW >65 years of age 
and attended only to emergencies. Surgical masks were made 
compulsory on floors, and repeated temperature checks of pa-
tients were done. They restricted patient visitors to one and for 
suspected patients they made an emergency isolation ward. Sur-
geries that were elective in nature were initially put on hold un-
til control measures were established. These surgeries were then 
started gradually to ensure familiarity with the new systems. 
With these measures, they reported that they had no case of 
nosocomial infection in their hospital (22).
More specific stringent measures were taken by the Amer-
ican Academy of Otolaryngology-Head and Neck Surgery 
(AAOHNS) (23) that included cancellation of all elective cases, 
converting all tracheotomies to percutaneous routes, keeping 
patients intubated for up to three weeks, operating in negative 
pressure operating room (OR), limiting the OR personnel with 
teams involved in cases of suspected COVID patients. All endo-
scopic or skull base procedures were abandoned and all consults 
for laryngoscopy, nasopharyngoscopy, nasal endoscopy, were 
suspended unless needed in urgent/emergent situation. All clin-
ic patients had their status rescheduled or offered telemedicine 
visits.
Use of personal protective equipment (PPE)
PPEs reduce the risk of nosocomial infections, as seen during 
the SARS outbreak (24). Thus, it was applied to mitigate the 
COVID-19 spread. Previous studies proved masks a significant 
source of contamination and otolaryngologists need to be adept 
with proper procedures and cautions when removing or re-us-
ing masks (25). However, a recent systematic review meta-ana-
lyzed data from four randomized control trials (RCT) to con-
clude that “Low certainty evidence suggests that medical masks 
and not resistant to oil (N95) respirators offer similar protec-
tion against viral respiratory infection including coronavirus in 
healthcare workers during non-aerosol-generating care.” They 
recommended N95 masks to be preserved for only aerosol-gen-
erating procedures (26).
The AAOHNS produced guidelines for the proper use of PPE. 
They advocated adherence to respiratory droplet precautions by 
using eye protection, gown, gloves and masks (N95 for proce-
dures), practice donning and removing PPE, confirm visibility, 
maintain communication, assess fidelity to perform safe endos-
copy and finally being alert to the possibility of asymptomatic 
COVID-19 infection (23).
Recommendations for Otolaryngologists/Head and Neck 
Surgeons
ENT/head and neck examination
Examination of patients presenting to otolaryngology clinic 
with routine complaints is a challenge in the era of this pan-
demic. Public Health England (PHE) advised ENT physicians 
to wear full PPE including N95 masks, gloves, gown and face 
shield or goggles for all type of examinations or procedures in 
all patients. They further suggested that for conditions not in-
volving the oral cavity such as neck and skin lesions, routine 
COVID PPE including gloves, surgical mask and apron could 
be used (27).
Procedural considerations
Majority of the procedures in otolaryngology, especially oral, 
nasal and airway surgeries put the surgeon at a higher risk of 
contracting the disease. Here we briefly discuss the most im-
portant procedures.
Role of tracheotomies
A major complication of COVID 19 is acute respiratory dis tress 
syndrome (ARDS) which requires mechanical ventilation, and 
the timing and the need for tracheotomy in these patients is a 
very pertinent question under the current conditions. In a small 
sample of 28 patients, Mattioli et al. (28) reported no differ-
ence between percutaneous and surgical tracheotomy in terms 
of timing and the number of affected team members; they also 
suggested to do the tracheotomy on 7th to 14th days in select-
ed patients. Guidelines issued by the Ear Nose Throat United 
Kingdom (ENT UK) recommends COVID 19 testing in all 
patients planned for tracheotomy. They further recommended 
using cuffed non-fenestrated tracheotomy tubes, not piercing 
the cuff of the endotracheal tube while performing tracheotomy 
and ceasing ventilation while the window in the trachea is being 
performed and prior to inserting the tracheostomy tube (29). 
Full PPE including gown, gloves, N95 mask, face shield should 
be used while performing the procedure.
Endoscopic sinus surgery
The viral load of COVID-19 is highest in the nasal cavity re-
gardless of whether the patient is symptomatic or asymptomatic 
(17). A case operated on in Wuhan, China for trans-nasal pi-
tuitary adenoma resulted in affecting more than 14 healthcare 
workers who were involved in that surgery (30). Due to this 
high potential for infectivity, we recommend that all cases of 
non-emergent nature should be deferred indefinitely until more 
data is available on this topic. In case of emergency, all neces-
sary precautions should be observed. The number of people in 
Turk Arch Otorhinolaryngol 2020; 58(2): 122-6
Dhanani et al.
COVID-19: Directions for Otolaryngologists124
the OR should be limited to only the necessary individuals, the 
procedure should be performed by the consultant surgeon and 
not by trainees to limit the time of exposure and all personnel 
involved in the case should use proper PPEs including gowns, 
gloves, N95 masks, face shields.
Ear surgery
Whether COVID-19 can involve the respiratory mucosa lin-
ing of the middle ear and the mastoid air cells is not known. 
Since COVID-19 can involve the rest of the airway mucosa, it 
is highly likely that it can also involve and infect the lining of the 
eustachian tube, the middle ear and the mastoid cells.
Drilling the mastoid bone creates droplets and aerosols, and in the 
presence of the virus, this procedure can cause all individuals in 
operating room to be infected. Mastoidectomy is therefore con-
sidered a high-risk procedure. It is important to take all the nec-
essary precautions and operate on only in emergency cases such 
as those with complex chronic ear conditions. Ideally, preoperative 
testing for COVID-19 should be performed in all patients under-
going ear surgery. Surgery should be deferred until the patient is 
disease free in case patient’s test is positive for COVID-19 (31).
The Role of Head and Neck Surgeon During the COVID-19 
Pandemic
Head and neck patients are known to practice self-referral (32). 
Hence it is essential to run outpatient services at times when 
the presentation of these patients to the emergency department 
would lead to increased demand on an already over-burdened 
department catering to patients of COVID-19.
Head and neck surgeons, together with anesthesiologists, are re-
sponsible for airway management. As more and more intensive 
care staff are exposed to the disease, ENT doctors will be crucial 
in the airway management of COVID-19 patients.
As the pandemic continues, there will be a rise in the number of 
patients that require prolonged mechanical ventilation, hence an 
increase in the number of tracheotomies performed. The mean 
duration of viral shedding is 20 days (33). Tracheotomy produc-
es aerosol and is a high-risk procedure in these patients (29).
ENT, as is the rest of medicine, will face a lot of challenges in the 
few weeks to come. Let’s stay healthy, so we can help our patients.
Challenges Faced by Developing Countries
Many developing countries have been pushed into crisis after 
the rapid spread of the novel coronavirus. Implementation of 
countrywide lockdowns and standard operating procedures have 
turned into great challenges in developing countries more than 
in developed countries.
Health-related challenges
The expenditure of funds on healthcare systems in developing 
countries is far less to enjoy better health services. Nearly all 
healthcare systems worldwide are coping with problems of high 
costs and lack of facilities.
Developing countries have the lowest number of intensive care 
units (ICU) per capita. The reason behind this is the cost of 
trained healthcare workers, infrastructure, and supplies that are 
required to establish a standard ICU (34).
People are devoid of the basic necessities that are essential for 
prevention, including facemasks, gloves and disinfectants. With 
the increasing number of cases, hospitals are facing a shortage of 
testing kits and unable to perform mass screening (35).
Social challenges
A major amount of population in developing countries is living 
in slums. In Mumbai, India, which is a city with a total surface 
area of 603 kilometers squared, has an estimated population of 
over 22 million that has doubled since 1991. The percentage of 
people living in slums is estimated to be as high as 41.3% (36). 
The population in such areas is so dense, and streets are not wide 
enough to follow the social distancing guidelines. This makes 
such areas a breeding ground for the virus. Many people do not 
have access to clean drinking water, they have to travel daily to 
fetch water from a local community water supply, where human 
interaction is not a choice but a compulsion.
Economic challenges
Most of the people live hand-to-mouth on daily wages and can-
not afford to stock up on food. So, they are faced with the dilem-
ma of either going out to work and risk being contaminated or 
staying at home and face extreme hunger. Once the lockdown is 
implemented, taking care of such people becomes a responsibil-
ity of the state. And the states of developing countries in such 
cases become handicapped.
Conclusion
COVID-19 has presented humanity with unprecedented chal-
lenges. Healthcare professionals are at considerably higher risk 
due to the close contact with these patients. Otorhinolaryngol-
ogists are at greater risk as the viral load is greatest in the naso-
pharynx and oral cavity. The evidence is limited and guidelines 
are being updated on almost daily basis. With proper use of 
PPE and a more stringent selection of patients for examination 
and surgical procedures the risk can be minimized. 
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